Cano Health, Inc. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020
Cash Flows (used in) from Operating Activities:
Net loss
Adjustments to reconcile net loss to net cash (used in) from operating activities:
Formation cost paid through promissory note — related party
Interest earned on marketable securities held in Trust Account
Depreciation and amortization expense (excluding accelerated amounts)
Change in fair value of contingent consideration
Change in fair value of warrant liabilities
Change in securities held at fair value
Intangible assets disposals
Goodwill impairment loss
Accelerated depreciation and amortization for property and equipment, and right-of-use assets
Abandonment of construction in progress
Loss on extinguishment of debt
Amortization of debt issuance costs
Non-cash lease expense
Write off of other receivable
Class A common shares issued for bonus award
Stock-based compensation, net
Paid in kind interest and fee expense
Credit loss on other assets
Net loss on Sale Transaction, Other Divestitures and other
Changes in operating assets and liabilities:
Prepaid expenses
Accrued expenses
Accounts receivable, net
Inventory
Other assets
Prepaid expenses and other current assets
Interest accrued due to sellers
Payment of paid in kind interest on extinguishment of debt
Deferred rent (Related parties comprised $0, $0 and $0 for the years ended December 31, 2021, 2020, and 2019, respectively)
Deferred revenue (Related parties comprised $0, $5,265 and $0 for the years ended December 31, 2021, 2020, and 2019, respectively)
Accounts payable and accrued expenses (Related parties comprised $(3,570), $2,669 and $0 for the years ended December 31, 2023, 2022 and 2021, respectively)
Other liabilities

Net cash (used in) provided by operating activities
Cash Flows from (used in) Investing Activities:
Investment of cash in Trust Account
Purchase of property and equipment (Related parties comprised $(983), $(7,864) and $(8,059) for the years ended December 31, 2023, 2022 and 2021, respectively)
Acquisitions of subsidiaries including non-compete intangibles, net of cash acquired
Payments to sellers
Other
Proceeds from Sale Transaction and Other Divestitures
Net cash provided by (used in) investing activities

Cash Flows from (used in) Financing Activities:
Proceeds from sale of Units, net of underwriting discounts paid
Proceeds from sale of Private Placement Warrants
Repayment of promissory note — related party
Payments of offering costs
Contributions from member
Distributions to member
Business combination and PIPE financing
Payments of long-term debt
Debt issuance costs
Proceeds from long-term debt
Prepayment fees on extinguishment of debt
Proceeds from CS Revolving Line of Credit
Repayments of CS Revolving Line of Credit
Proceeds from insurance financing arrangements
Payments of principal on insurance financing arrangements
Principal payments under finance leases
Repayment of equipment loans
Employee stock purchase plan contributions
Employee Stock Purchase Plan withholding tax payments
Other
Net Cash Provided by (Used in) Financing Activities, Total

Net Change in Cash
Net increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of year
Cash, cash equivalents and restricted cash at end of period
Initial classification of Class A ordinary shares subject to possible redemption
Change in value of Class A ordinary shares subject to possible redemption
Deferred underwriting fee payable
Payment of prepaid expenses through promissory note — related party
Payment of offering costs through promissory note — related party
Offering cost paid directly by Sponsor from proceeds of issuance of Class B ordinary shares
Payment of accrued expenses through promissory note — related party
Supplemental cash flow information:
Interest paid
Income taxes paid
Non-cash investing and financing activities:
Right-of-use assets obtained in exchange of lease liabilities
Additional principal additions from long term debt
Debt discount addition
Issuance of Class A common stock for acquisitions
Issuance of securities in PCIH in connection with acquisitions
Contingent consideration liability in connection with acquisitions
Contingent consideration assets in connection with acquisitions
Due to sellers in connection with acquisitions
Changes to construction in process funded through accounts payable
Sale Proceeds Reflected Through Accounts Payable
Humana Affiliate Provider clinic leasehold improvements
Employee Stock Purchase Plan issuance
Capital lease obligations entered into for property and equipment
Warrants issued
Equipment loan obligations entered into for property and equipment
Issuance of security in exchange for balance due to sellers

Comments